1-1 of 1
Scott Verrow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary Endpoint for Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Kristy Drafahl, David C Smith, Cristen Graham, Christine Glynn, Cindy Spittle, Scott Verrow, Victor M. Rivera, PhD, Shouryadeep Srivastava, MBBS, PhD, Kevin Hawkins, Chad Galderisi, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 1558.
https://doi.org/10.1182/blood-2018-99-113172
Published: 2018